Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Orthofix Medical (OFIX) over the last 16 years, with Q3 2025 value amounting to $55.8 million.

  • Orthofix Medical's Other Non-Current Liabilities rose 1206.63% to $55.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.8 million, marking a year-over-year increase of 1206.63%. This contributed to the annual value of $46.7 million for FY2024, which is 609.58% down from last year.
  • According to the latest figures from Q3 2025, Orthofix Medical's Other Non-Current Liabilities is $55.8 million, which was up 1206.63% from $55.9 million recorded in Q2 2025.
  • Orthofix Medical's Other Non-Current Liabilities' 5-year high stood at $55.9 million during Q2 2025, with a 5-year trough of $14.0 million in Q4 2021.
  • Moreover, its 5-year median value for Other Non-Current Liabilities was $46.7 million (2024), whereas its average is $39.8 million.
  • As far as peak fluctuations go, Orthofix Medical's Other Non-Current Liabilities tumbled by 6733.16% in 2021, and later skyrocketed by 17784.93% in 2023.
  • Orthofix Medical's Other Non-Current Liabilities (Quarter) stood at $14.0 million in 2021, then soared by 35.34% to $18.9 million in 2022, then skyrocketed by 163.0% to $49.7 million in 2023, then fell by 6.1% to $46.7 million in 2024, then rose by 19.55% to $55.8 million in 2025.
  • Its last three reported values are $55.8 million in Q3 2025, $55.9 million for Q2 2025, and $46.2 million during Q1 2025.